Breast Cancer Trial, Not Yet Recruiting NCT06981182 Sponsor: University of Sunderland Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT06981182
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Members of churches taking part in this study, located in the North East of England, Leeds, or Scotland.
  • People who identify as Black.
  • Women between the ages of 25 and 74.
  • Men between the ages of 50 and 74.
  • People who are not fully up to date with all the cancer screening tests they are eligible for — for example, a woman who is up to date with breast screening but not cervical or bowel screening would still meet this criterion.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are not members of the participating churches in the North East of England, Leeds, or Scotland.
  • People who do not identify as Black.
  • Women who are younger than 25 or older than 74.
  • Men who are younger than 50 or older than 74.
  • People who are fully up to date with all cancer screening tests they are eligible for.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0191 5153445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University of Sunderland
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Narrative description of feasibility; (1) Number of churches recruited into the study; (2) Number of churches that consent to randomisation will be documented; (3) Number of participants recruited; (4) Distribution of recruited participants across age groups and screening programmes; (5) Proportion of participants retained at 3-month follow up; (6) Acceptability of the informed consent procedures to participants; (7) Suitability of data collection tools; (8) Proportion of participants providing consent to provide access to NHS screening data; (9) Feasibility of accessibility of NHS screening d...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov